Terms: = Skin cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Clinical Outcome
17 results:
1. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
[TBL] [Abstract] [Full Text] [Related]
2. Emerging Role of IL-4-Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous Melanoma.
Ramspott JP; Bekkat F; Bod L; Favier M; Terris B; Salomon A; Djerroudi L; Zaenker KS; Richard Y; Molinier-Frenkel V; Castellano F; Avril MF; Prévost-Blondel A
J Invest Dermatol; 2018 Dec; 138(12):2625-2634. PubMed ID: 30048651
[TBL] [Abstract] [Full Text] [Related]
3. Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma.
Falkenius J; Johansson H; Tuominen R; Frostvik Stolt M; Hansson J; Egyhazi Brage S
BMC Cancer; 2017 Aug; 17(1):584. PubMed ID: 28851300
[TBL] [Abstract] [Full Text] [Related]
4. Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients.
Massi D; Romano E; Rulli E; Merelli B; Nassini R; De Logu F; Bieche I; Baroni G; Cattaneo L; Xue G; Mandalà M
Eur J Cancer; 2017 Jun; 78():70-81. PubMed ID: 28412591
[TBL] [Abstract] [Full Text] [Related]
5. Baseline Peripheral Blood Biomarkers Associated with clinical outcome of Advanced Melanoma Patients Treated with Ipilimumab.
Martens A; Wistuba-Hamprecht K; Geukes Foppen M; Yuan J; Postow MA; Wong P; Romano E; Khammari A; Dreno B; Capone M; Ascierto PA; Di Giacomo AM; Maio M; Schilling B; Sucker A; Schadendorf D; Hassel JC; Eigentler TK; Martus P; Wolchok JD; Blank C; Pawelec G; Garbe C; Weide B
Clin Cancer Res; 2016 Jun; 22(12):2908-18. PubMed ID: 26787752
[TBL] [Abstract] [Full Text] [Related]
6. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
[TBL] [Abstract] [Full Text] [Related]
7. PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma Patients.
Kakavand H; Wilmott JS; Menzies AM; Vilain R; Haydu LE; Yearley JH; Thompson JF; Kefford RF; Hersey P; Long GV; Scolyer RA
Clin Cancer Res; 2015 Jul; 21(14):3140-8. PubMed ID: 25609064
[TBL] [Abstract] [Full Text] [Related]
8. IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.
Sim GC; Martin-Orozco N; Jin L; Yang Y; Wu S; Washington E; Sanders D; Lacey C; Wang Y; Vence L; Hwu P; Radvanyi L
J Clin Invest; 2014 Jan; 124(1):99-110. PubMed ID: 24292706
[TBL] [Abstract] [Full Text] [Related]
9. High expression of foxp3 in primary melanoma is associated with tumour progression.
Gerber AL; Münst A; Schlapbach C; Shafighi M; Kiermeir D; Hüsler R; Hunger RE
Br J Dermatol; 2014 Jan; 170(1):103-9. PubMed ID: 24116716
[TBL] [Abstract] [Full Text] [Related]
10. Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++foxp3+ regulatory T-cells in advanced melanoma patients.
Ridolfi L; Petrini M; Granato AM; Gentilcore G; Simeone E; Ascierto PA; Pancisi E; Ancarani V; Fiammenghi L; Guidoboni M; de Rosa F; Valmorri L; Scarpi E; Nicoletti SV; Baravelli S; Riccobon A; Ridolfi R
J Transl Med; 2013 May; 11():135. PubMed ID: 23725550
[TBL] [Abstract] [Full Text] [Related]
11. Immune cell profile of sentinel lymph nodes in patients with malignant melanoma - foxp3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome.
Mohos A; Sebestyén T; Liszkay G; Plótár V; Horváth S; Gaudi I; Ladányi A
J Transl Med; 2013 Feb; 11():43. PubMed ID: 23418928
[TBL] [Abstract] [Full Text] [Related]
12. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
[TBL] [Abstract] [Full Text] [Related]
13. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.
Bronkhorst IH; Vu TH; Jordanova ES; Luyten GP; Burg SH; Jager MJ
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5370-8. PubMed ID: 22743317
[TBL] [Abstract] [Full Text] [Related]
14. Expression of the T-cell regulatory marker foxp3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract] [Full Text] [Related]
15. Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node.
Ma MW; Medicherla RC; Qian M; Vega-Saenz de Miera E; Friedman EB; Berman RS; Shapiro RL; Pavlick AC; Ott PA; Bhardwaj N; Shao Y; Osman I; Darvishian F
Mod Pathol; 2012 Jul; 25(7):1000-10. PubMed ID: 22425909
[TBL] [Abstract] [Full Text] [Related]
16. [Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma--a study of relationship between immuno-reaction and clinical outcome].
Kotera Y; Kougen Y; Aruga A; Yamamoto M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1964-6. PubMed ID: 20037292
[TBL] [Abstract] [Full Text] [Related]
17. Absence of Granzyme B positive tumour-infiltrating lymphocytes in primary melanoma excisional biopsies is strongly associated with the presence of sentinel lymph node metastasis.
van Houdt IS; Sluijter BJ; van Leeuwen PA; Moesbergen LM; Hooijberg E; Meijer CJ; de Gruijl TD; Oudejans JJ; Boven E
Cell Oncol; 2009; 31(5):407-13. PubMed ID: 19759420
[TBL] [Abstract] [Full Text] [Related]
